PANASONIC
26.5.2020 12:50:05 CEST | Business Wire | Press release
Panasonic Center Tokyo (3-5-1 Ariake, Koto-ku, Tokyo, Japan. Referred to as "PC Tokyo"), the corporate global communications hub for Panasonic, has been conducting various communication activities as a corporate pavilion through exhibitions and offline events.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005385/en/
Due to the unprecedented circumstances around the world today, people's daily lives and values have been significantly impacted. We, at Panasonic, believe a new approach blending online and offline communication activities will be an essential element for corporate pavilions now more than ever.
Based on this perspective, we have decided to host an online event called "The power to create the future", on Sunday, May 31, 2020. An event dedicated to children, who we believe have the ability to become "change makers" and bring a positive impact to society, to create a better world.
The theme of the event is "STEAM education*", a very important element required for future education as the world is rapidly changing. During the event, STEAM professionals will conduct a workshop which will give the participants an opportunity to think and understand more about STEAM in their daily lives. Olympian Katie Ledecky will also join the event to introduce the Dive Into STEM Education, Powered by Panasonic program.
Katie Ledecky's Dive Into STEM Education Powered by Panasonic is an interactive educational program created to inspire students to pursue careers in science, technology, engineering and mathematics.
The students participating in the event will be divided into different groups where they will conduct a series of interviews with our guests to learn more about STEAM, and then will make a presentation about what they have learned. At the end of the event, participants will hear from Katie, who is actively working on educational support activities for younger generations.
PC Tokyo aims to proactively support the education program of younger generations by providing fresh contents such as videos of online events available on the pavilion's website.
Message from Katie Ledecky towards the event
"I am thrilled to join Panasonic Center Tokyo to promote STEM education to a group of Japanese students on May 31st.
All are welcome to join our training workshop. Hope to see you soon."
Video: “Katie Ledecky's Dive Into STEM Education Powered by Panasonic”
https://youtu.be/31DmQXq0sTw
*STEAM education is an educational method which was proposed by adding Art to "STEM education"; a method to learn about Science, Technology, Engineering, and Mathematics comprehensively.
STEAM education was introduced in the United States to contribute to the development of younger generations to inspire them to pursue diverse career fields. This method is also attracting a lot of attention in Japan in recent years.
"The power to create the future" Event outline
Date
Saturday, May 30, 2020 at 6:00pm-7:40pm PDT / 9:00pm-10:40pm EDT
Sunday, May 31, 2020 at 10:00am-11:40am JST
Place
Live stream of the online event: https://youtu.be/aiLyPX7SmTM
Details: https://www.panasonic.com/global/corporate/center-tokyo/en.html#steam_0531
*The live stream is recorded and can be viewed afterwards.
Target
Junior and senior high school students, educators, and those who have interest in STEAM education
Cooperation
Kyodo News (junior press), EverFi (contents for the event)
*The event will be conducted in English. Admission free.
About Panasonic
Panasonic Corporation is a global leader developing innovative technologies and solutions for wide-ranging applications in the consumer electronics, housing, automotive, and B2B sectors. The company, which celebrated its 100th anniversary in 2018, operates 528 subsidiaries and 72 associated companies worldwide and reported consolidated net sales of 7.49 trillion yen for the year ended March 31, 2020. Committed to pursuing new value through collaborative innovation, the company uses its technologies to create a better life and a better world for customers. Learn more about Panasonic: https://www.panasonic.com/global .
Source: https://news.panasonic.com/global/topics/2020/78373.html
Related Links
Panasonic Center Tokyo official website
https://panasonic.com/global/center-tokyo/en/
Event Reports - Panasonic Center TOKYO
https://www.panasonic.com/global/corporate/center-tokyo/en/event_report.html#StayHome_contents
Video: Panasonic Partners With The Michael Phelps Foundation #whatmovesus
https://channel.panasonic.com/contents/28784/
Video: Team Panasonic is forward moving #whatmovesus
https://channel.panasonic.com/contents/28785/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005385/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom